Recently, Liu et al. confirmed that AKT activation suppresses the activity of GSK3β and stabilizes Nrf2, which decreasing sensitivity to ferroptosis in the isocitrate dehydrogenase gene-mutated cancer cells [50]. The gene discussed is NFE2L2; the disease is cancer.